Skip to content
Let's Talk

Pharmaceutical Market ResearchCase 01 of 10

Understanding how cardiologists choose treatments after a heart attack

A pharmaceutical company

  • RegionMetros and tier-2 cities
  • Scope250 cardiologists, 20 interviews
  • Timeline6 weeks
  • MarketsIndia
Download the PDF Discuss a similar project
01

Industry overview

What is shaping pharmaceutical

Pharmaceutical and medical-device companies need evidence from doctors, pharmacists and patients, gathered with verified respondents, strict confidentiality and careful questionnaire design.

  • Prescribing behaviour is shaped by evidence, experience and access
  • Pharmacies influence brand substitution and adherence
  • Patient journeys reveal unmet needs between visits
02

Client background

A pharmaceutical company, working in Metros and tier-2 cities. Client identity is withheld to protect confidentiality.

Organisation
A pharmaceutical company
Sector
Pharmaceutical
Team engaged
Market Research
Services
Healthcare panel, Quantitative research, Qualitative research
03

Client challenge

The company wanted to understand prescribing patterns and decision drivers for post-heart-attack therapy, to shape its medical education programme.

04

Research objectives

  • Deliver on the brief: understanding how cardiologists choose treatments after a heart attack.
  • Understand the views, needs and behaviour of cardiologists.
  • Measure how widespread each pattern is, and explain the reasons behind it.
  • Give the client evidence it can act on within 6 weeks.
05

Target audience

The work focused on 250 cardiologists.

  • cardiologists250

Audiences we typically reach in pharmaceutical

Physicians and specialistsPharmacists and chemistsNurses and allied HCPsPatients and caregiversHospital procurement teams

06

Geographic coverage

Coverage: Metros and tier-2 cities. Market: India.

  • India
07

Research methodology

A mixed-method design: structured research measured how widespread each pattern was, and qualitative conversations explained why.

  1. 1Brief
  2. 2Online HCP survey
  3. 3In-depth interviews
  4. 4Insight

Verified cardiologists from our healthcare panel completed a survey on treatment choices, guidelines, patient factors and evidence needs. In-depth interviews explored reasoning. Adverse event reporting procedures were agreed with the client before fieldwork.

Healthcare panelQuantitative researchQualitative research

08

Sampling strategy

cardiologists
250
  • Healthcare professionals and patients were screened on specialty, setting or condition, and professionals were verified before taking part.
  • Online respondents were drawn from verified panel members who matched the screening criteria, with quotas on key profile attributes.
  • Qualitative participants were recruited purposively to cover the full range of experiences that mattered, rather than for statistical representation.
09

Data collection

interviews
20
Brief & design Sampling & set-up Fieldwork Analysis Reporting Indicative split of the 6-week timeline.
  • The online survey was mobile-friendly and offered in respondents' languages.
  • Interviews and discussions were led by experienced moderators using a guide agreed with the client.
10

Data quality & validation

  • Digital fingerprinting and duplicate checks
  • Attention, speed and straight-lining checks
  • Review of open-ended answers
  • Recordings and transcripts for every session
  • Re-screening of qualitative recruits
  • Verification of healthcare professionals
  • Logic and range checks on the final data
  • Work carried out under our ISO 20252 quality procedures
11

Data analysis

  • Cross-tabulation by key groups and locations
  • Significance testing on the differences that mattered
  • Thematic coding of interviews and discussions
  • Journey and decision mapping
12

Key findings

  • Cardiologists in tier-2 cities faced more patient affordability and adherence challenges.
Context of practice shaped decisions as much as clinical evidence.
13

Recommendations

  • Build on the core insight: context of practice shaped decisions as much as clinical evidence.
  • Focus effort where the evidence was strongest: cardiologists in tier-2 cities faced more patient affordability and adherence challenges.
  • Re-measure after the changes to confirm the effect.
14

Business impact

  • The company refocused its education programme on adherence support and practical guidance for those settings.

What changed in the business as a result of the work. Impact is described qualitatively.

15

Deliverables & next steps

  • Insight report and management presentation
  • Cleaned data file and data tables
  • Interview summaries and key verbatims
  • Repeat the measure after changes are in place to track progress.
  • A natural follow-on question: how do doctors choose between therapies?

Client identity is withheld to protect confidentiality.

More pharmaceutical case studies

  1. 02caseMapping the patient journey for people living with diabetesA pharmaceutical company
  2. 03caseUnderstanding pharmacist recommendations at the counterA consumer health company
  3. 04caseUsability testing a home blood pressure monitorA medical device company
All pharmaceutical case studies

Want results like these?

Tell us about your objectives. We'll recommend an approach and confirm feasibility within one working day.

Request a QuoteTalk to an Expert